BEAM logo

Beam Therapeutics (BEAM) Depreciation and amortization

annual D&A:

$31.59M+$2.06M(+6.98%)
December 31, 2024

Summary

  • As of today (June 30, 2025), BEAM annual depreciation & amortization is $31.59 million, with the most recent change of +$2.06 million (+6.98%) on December 31, 2024.
  • During the last 3 years, BEAM annual D&A has risen by +$24.14 million (+324.01%).
  • BEAM annual D&A is now at all-time high.

Performance

BEAM Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

quarterly D&A:

$5.53M-$9.58M(-63.42%)
March 31, 2025

Summary

  • As of today (June 30, 2025), BEAM quarterly depreciation & amortization is $5.53 million, with the most recent change of -$9.58 million (-63.42%) on March 31, 2025.
  • Over the past year, BEAM quarterly D&A has increased by +$97.00 thousand (+1.79%).
  • BEAM quarterly D&A is now -63.42% below its all-time high of $15.11 million, reached on December 31, 2024.

Performance

BEAM quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

TTM D&A:

$31.69M+$97.00K(+0.31%)
March 31, 2025

Summary

  • As of today (June 30, 2025), BEAM TTM depreciation & amortization is $31.69 million, with the most recent change of +$97.00 thousand (+0.31%) on March 31, 2025.
  • Over the past year, BEAM TTM D&A has increased by +$1.38 million (+4.54%).
  • BEAM TTM D&A is now at all-time high.

Performance

BEAM TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

BEAM Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.0%+1.8%+4.5%
3 y3 years+324.0%+66.9%+238.4%
5 y5 years+801.9%+402.6%+719.3%

BEAM Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+324.0%-63.4%+66.9%at high+238.4%
5 y5-yearat high+801.9%-63.4%+402.6%at high+719.3%
alltimeall timeat high+4760.5%-63.4%+652.1%at high+4211.6%

BEAM Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$5.53M(-63.4%)
$31.69M(+0.3%)
Dec 2024
$31.59M(+7.0%)
$15.11M(+176.0%)
$31.59M(+0.7%)
Sep 2024
-
$5.47M(-1.8%)
$31.36M(+0.9%)
Jun 2024
-
$5.58M(+2.7%)
$31.07M(+2.5%)
Mar 2024
-
$5.43M(-63.5%)
$30.32M(+2.7%)
Dec 2023
$29.53M(+30.8%)
$14.88M(+186.9%)
$29.53M(+9.3%)
Sep 2023
-
$5.19M(+7.7%)
$27.02M(+6.8%)
Jun 2023
-
$4.82M(+3.6%)
$25.31M(+5.8%)
Mar 2023
-
$4.65M(-62.4%)
$23.91M(+5.9%)
Dec 2022
$22.58M(+203.0%)
$12.37M(+256.3%)
$22.58M(+75.9%)
Sep 2022
-
$3.47M(+1.6%)
$12.84M(+15.5%)
Jun 2022
-
$3.42M(+3.2%)
$11.11M(+18.7%)
Mar 2022
-
$3.31M(+25.7%)
$9.37M(+25.7%)
DateAnnualQuarterlyTTM
Dec 2021
$7.45M(+57.4%)
$2.63M(+50.5%)
$7.45M(+22.4%)
Sep 2021
-
$1.75M(+4.9%)
$6.09M(+9.6%)
Jun 2021
-
$1.67M(+19.4%)
$5.56M(+10.4%)
Mar 2021
-
$1.40M(+9.9%)
$5.03M(+6.3%)
Dec 2020
$4.74M(+35.2%)
$1.27M(+4.4%)
$4.74M(+6.0%)
Sep 2020
-
$1.22M(+6.4%)
$4.46M(+7.5%)
Jun 2020
-
$1.15M(+4.1%)
$4.16M(+7.4%)
Mar 2020
-
$1.10M(+9.8%)
$3.87M(+10.4%)
Dec 2019
$3.50M(+438.9%)
$1.00M(+10.4%)
$3.50M(+40.1%)
Sep 2019
-
$908.00K(+5.8%)
$2.50M(+57.0%)
Jun 2019
-
$858.00K(+16.7%)
$1.59M(+116.7%)
Mar 2019
-
$735.00K
$735.00K
Dec 2018
$650.00K
-
-

FAQ

  • What is Beam Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Beam Therapeutics?
  • What is Beam Therapeutics annual D&A year-on-year change?
  • What is Beam Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Beam Therapeutics?
  • What is Beam Therapeutics quarterly D&A year-on-year change?
  • What is Beam Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Beam Therapeutics?
  • What is Beam Therapeutics TTM D&A year-on-year change?

What is Beam Therapeutics annual depreciation & amortization?

The current annual D&A of BEAM is $31.59M

What is the all time high annual D&A for Beam Therapeutics?

Beam Therapeutics all-time high annual depreciation & amortization is $31.59M

What is Beam Therapeutics annual D&A year-on-year change?

Over the past year, BEAM annual depreciation & amortization has changed by +$2.06M (+6.98%)

What is Beam Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of BEAM is $5.53M

What is the all time high quarterly D&A for Beam Therapeutics?

Beam Therapeutics all-time high quarterly depreciation & amortization is $15.11M

What is Beam Therapeutics quarterly D&A year-on-year change?

Over the past year, BEAM quarterly depreciation & amortization has changed by +$97.00K (+1.79%)

What is Beam Therapeutics TTM depreciation & amortization?

The current TTM D&A of BEAM is $31.69M

What is the all time high TTM D&A for Beam Therapeutics?

Beam Therapeutics all-time high TTM depreciation & amortization is $31.69M

What is Beam Therapeutics TTM D&A year-on-year change?

Over the past year, BEAM TTM depreciation & amortization has changed by +$1.38M (+4.54%)
On this page